L-dopa stimulates the release of [3H]gamma-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats

Neurosci Lett. 1991 Jan 2;121(1-2):223-6. doi: 10.1016/0304-3940(91)90690-u.

Abstract

L-DOPA stimulated the K(+)-induced [3H]GABA (gamma-aminobutyric acid) release from slices of substantia nigra pars reticulata, entopeduncular nucleus, globus pallidus and caudate-putamen isolated from the ipsilateral side of 6-hydroxydopamine-lesioned rats, but the release from ipsilateral subthalamic slices was not affected. In substantia nigra, L-DOPA stimulation (EC50 = 1 microM) of [3H]GABA release was dose-dependently blocked (IC50 = 0.1 microM for the stimulation caused by 10 microM L-DOPA) by the D1 antagonist SCH 23390, but was not affected by (-)-sulpiride, a D2 antagonist. SCH 23390 also blocked the stimulation in the other nuclei. The DOPA decarboxylase inhibitor NSD-1015 (500 microM) did not prevent the stimulation induced by L-DOPA in all of the studied nuclei. The results suggest that L-DOPA is able to activate D1 receptors located on the terminals of striatal projections via the dopamine formed by a decarboxylation mediated by an NSD-1015-resistant enzyme. Activation of the presynaptic D1 receptors results in stimulation of GABA release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Basal Ganglia / drug effects
  • Basal Ganglia / metabolism*
  • Benzazepines / analogs & derivatives
  • Benzazepines / metabolism
  • Benzazepines / pharmacology
  • Brain Chemistry / drug effects
  • Dopamine Antagonists
  • Hydrazines / pharmacology
  • Hydroxydopamines
  • In Vitro Techniques
  • Levodopa / pharmacology*
  • Male
  • Nerve Degeneration
  • Oxidopamine
  • Potassium / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Sulpiride / pharmacology
  • Sympathectomy, Chemical*
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • 8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol
  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Benzazepines
  • Dopamine Antagonists
  • Hydrazines
  • Hydroxydopamines
  • Levodopa
  • gamma-Aminobutyric Acid
  • Sulpiride
  • Oxidopamine
  • 3-hydroxybenzylhydrazine
  • Potassium